Latest / Stock Movers / Bending Spoons Soars, Bank of America Drops, Liquidia Soars After United Therapeutics Settlement
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 2: Let's take a look at some stocks on the move
- 0:18Speaker 2: right now.
- 0:18Speaker 1: Chloe Milley is our Bloomberg earnings reporter. The first one
- 0:21Speaker 1: that I'm looking at today is Bending Spoon. So we're
- 0:24Speaker 1: seeing a real surge this morning in the shares because
- 0:27Speaker 1: Berkshire Hathaway is investing an additional $ 330 million in the company.
- 0:33Speaker 1: And when I say such, I'm not exaggerating. The shares
- 0:36Speaker 1: are up more than 50% this morning on the back
- 0:39Speaker 1: of this. And the latest investment means that the stake
- 0:42Speaker 1: in Bending Spoons is now at 4%. And that's just
- 0:46Speaker 1: a few months after Berkshire backed the IPO with $ 600 million.
- 0:49Speaker 1: And For Benning Spoons, that means more capital to pursue
- 0:55Speaker 1: a lot of different deals, which is exactly what it
- 0:57Speaker 1: needs because it continues to buy up all those digital businesses.
- 1:02Speaker 1: That's really the sort of business model of that company,
- 1:04Speaker 1: acquiring those established tech companies, shaking up the operations and
- 1:09Speaker 1: trying to improve that profitability. And there's some really well-known
- 1:12Speaker 1: names in that portfolio, names like WeTransfer, Vimeo, even Evan
- 1:17Speaker 1: Bright as well. And so we're seeing this bit of
- 1:19Speaker 1: confidence from Berkshire count for a lot for investors and
- 1:23Speaker 1: really driving up those shares.
- 1:25Speaker 2: And Chloe, what else are we looking at this morning?
- 1:27Speaker 1: We're looking at Bank of America. John was mentioning it
- 1:30Speaker 1: a little bit. And it's a very different story. It's
- 1:33Speaker 1: been a rough morning. A rough morning for that company.
- 1:35Speaker 1: It missed estimates across equities and fixed income trading. And
- 1:39Speaker 1: that's really the key difference with some of its peers.
- 1:42Speaker 1: So we have seen some weakness in bond trading for
- 1:45Speaker 1: Goldman Sachs and from J.P.
- 1:46Speaker 2: Morgan.
- 1:47Speaker 1: But actually quite resilient stock trading, whereas here for Bank
- 1:50Speaker 1: of America, it's just weak across the board. And in
- 1:53Speaker 1: addition to that, we also have the bank announcing a
- 1:56Speaker 1: $ 1. 2 billion charge. for fines that are related to money
- 2:00Speaker 1: laundering and sanctions violations as well. So that's a big hit,
- 2:04Speaker 1: of course, on its own. But then there's also kind
- 2:07Speaker 1: of longer term implications to consider when it comes to
- 2:11Speaker 1: higher compliance costs going forward, you know, to strengthen those
- 2:14Speaker 1: monitoring systems, to train up personnel as well and everything.
- 2:18Speaker 1: So we've got the big penalty. We've got the longer
- 2:20Speaker 1: term implications and disappointing results. And so all of that
- 2:24Speaker 1: is really weighing on the shares this morning. And some
- 2:28Speaker 1: analysts are saying this is so far the worst of
- 2:30Speaker 1: those big bank results compared to all those other peers
- 2:34Speaker 1: that have been reporting this week. One bright spot is
- 2:37Speaker 1: that the consumer seems to be quite resilient. There's less
- 2:40Speaker 1: money set aside for souring loans than what was expected.
- 2:43Speaker 1: All right. Thank you for finding the silver lining in
- 2:47Speaker 1: all of this there. One bright spot. Last stock that
- 2:49Speaker 1: you're watching. Yeah, it's Liquidia, which is a biotech company
- 2:53Speaker 1: soaring this morning after reaching a settlement with a fellow
- 2:56Speaker 1: biotech company called United Therapeutics. And so there was a
- 3:00Speaker 1: dispute between the two firms that was centering around a
- 3:03Speaker 1: patent infringement. And there was a court ruling that found
- 3:06Speaker 1: that Liquidia's product, which is called eutrepia, is a type
- 3:10Speaker 1: of inhaler, crossed the legal boundaries set by Unitas Intellectual Property.
- 3:15Speaker 1: And so now there's this settlement which essentially removes this
- 3:18Speaker 1: huge overhang on the stock. Liquidia will pay around $ 380
- 3:22Speaker 1: million in multiple installments over 2026 and 2027 to resolve
- 3:24Speaker 1: that litigation issue. And some analysts are saying this is
- 3:31Speaker 1: better than the best case scenario. And so that's really
- 3:33Speaker 1: driving up that stock as well this morning.
- 3:36Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:40Speaker 2: us throughout the day for the latest roundup of companies
- 3:43Speaker 2: making news on Wall Street. And for the latest market
- 3:46Speaker 2: moving headlines, listen to Bloomberg Radio live. Catch us on YouTube,
- 3:51Speaker 2: Bloomberg.com and on Apple CarPlay and Android Auto with the
- 3:54Speaker 2: Bloomberg Business app.